Medicare Enrolled
Dr. Deelip Chatterjee, M.D.
Pulmonary Disease · West Paterson, NJ
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Chatterjee from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Chatterjee?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Chatterjee
Dr. Deelip Chatterjee is a pulmonary disease specialist in West Paterson, NJ, with 19 years of NPI registration. Based on federal Medicare data, Dr. Chatterjee performed 5,213 Medicare services across 984 unique beneficiaries.
Between the years covered by Open Payments, Dr. Chatterjee received a total of $4,150 from 32 pharmaceutical and/or device companies across 246 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pulmonary disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Chatterjee is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 4% volume in NJ
$4,150 industry payments
Medicare Practice Summary
Medicare Utilization ↗5,213
Medicare services
Top 4% in NJ for pulmonary disease
984
Unique beneficiaries
$39
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~274 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
1,610 | $0 | $1 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
810 | $114 | $147 |
| Remote patient monitoring management, 20 min/month Management based on results from remote vital sign monitoring for the first 20 minutes per calendar month. |
438 | $43 | $58 |
| Injection, levofloxacin, 250 mg | 297 | $1 | $7 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
253 | $36 | $46 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
189 | $13 | $16 |
| Ceftriaxone antibiotic injection This code represents the administration of ceftriaxone sodium, an antibiotic medication. The charge is calculated for every 250 mg of the drug administered. |
189 | $0 | $7 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
174 | $81 | $106 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
147 | $61 | $87 |
| Albuterol inhalation solution, 1 mg A unit dose of FDA-approved albuterol solution administered via durable medical equipment for inhalation. |
142 | $0 | $1 |
| Inhaled ipratropium bromide, unit dose Administration of FDA-approved ipratropium bromide inhalation solution via durable medical equipment in a unit dose form. |
142 | $0 | $1 |
| Positive pressure ventilator therapy A therapy procedure that uses a positive pressure ventilator to assist with breathing. |
124 | $56 | $74 |
| Inhalation treatment for acute airway obstruction, first hour This procedure involves administering inhaled medication to treat acute airway obstruction during the first hour of treatment. |
100 | $57 | $74 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
77 | $27 | $37 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
44 | $19 | $26 |
| Spirometry test before and after medication A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication. |
38 | $36 | $55 |
| Lung volume measurement test A test that measures the largest amount of air you can breathe in and out. It evaluates the total capacity of your lungs. |
37 | $14 | $21 |
| Lung volume test using sensors A test that measures the amount of air in the lungs using sensors. |
37 | $51 | $65 |
| Pulmonary gas exchange test A test to examine how well the lungs exchange gases. |
37 | $54 | $71 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
29 | $160 | $203 |
| Advance care planning consultation, first 30 min A session focused on discussing and documenting future healthcare preferences and goals. This service covers the initial 30 minutes of the planning discussion. |
24 | $73 | $94 |
| Annual alcohol misuse screening, 5 to 15 minutes | 24 | $21 | $22 |
| Annual depression screening | 24 | $21 | $22 |
| Annual intensive behavioral therapy for cardiovascular disease, 15 minutes A yearly, in-person session focused on intensive behavioral therapy to help manage cardiovascular disease. The session lasts for 15 minutes and is conducted with the patient individually. |
24 | $29 | $30 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
23 | $146 | $149 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
21 | $21 | $27 |
| Sleep study with continuous airway pressure, age 6+ A sleep study conducted in a sleep lab that monitors breathing and other body functions while administering continuous airway pressure. This test is performed on patients aged 6 years or older. |
18 | $592 | $852 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
18 | $51 | $64 |
| Complete ultrasound of abdomen A diagnostic imaging test that uses sound waves to create detailed pictures of the organs and structures within the abdomen. |
17 | $104 | $145 |
| Ultrasound of head and neck blood flow, bilateral An ultrasound exam that uses sound waves to visualize and assess blood flow in the vessels of both the head and the neck. |
16 | $181 | $240 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
15 | $148 | $241 |
| Quadrivalent influenza vaccine, cell-culture derived A flu shot containing four strains of influenza virus, produced using cell culture technology rather than eggs. This formulation is free from preservatives and antibiotics. |
14 | $32 | $33 |
| Ultrasound of arm and leg arteries This procedure uses sound waves to create images of the blood vessels in the arms and legs. It allows healthcare providers to examine the structure and blood flow within these arteries. |
13 | $72 | $103 |
| Pneumococcal vaccine, 13-valent | 12 | $253 | $262 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
12 | $34 | $50 |
| Pneumonia vaccine administration This procedure involves the injection of a vaccine to protect against pneumococcal disease. It is administered by a healthcare provider. |
12 | $31 | $32 |
| Obesity behavioral counseling, 15 minutes A 15-minute face-to-face session focused on behavioral counseling to help manage obesity. |
12 | $28 | $30 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
5.4% high complexity
44.7% medium
49.9% routine
Industry Payment Transparency
Open Payments through 2024 ↗$4,150
Total received (2018-2024)
Avg $593/year across 7 years
Top 37% in NJ for pulmonary disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
32
Companies
246
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,150 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$623
2023
$640
2022
$613
2021
$539
2020
$194
2019
$964
2018
$577
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$178
GlaxoSmithKline, LLC.
$154
PFIZER INC.
$99
Actelion Pharmaceuticals US, Inc.
$58
Avadel CNS Pharmaceuticals, LLC
$52
Insmed, Inc.
$34
Amgen Inc.
$30
Novo Nordisk Inc
$19
Top 3 companies account for 69.2% of 2024 payments
All-time payments by company (2018-2024) ›
GlaxoSmithKline, LLC.
$1,532
AstraZeneca Pharmaceuticals LP
$924
Boehringer Ingelheim Pharmaceuticals, Inc.
$357
Amgen Inc.
$185
PFIZER INC.
$159
Actelion Pharmaceuticals US, Inc.
$122
Radius Health, Inc.
$88
Lilly USA, LLC
$70
Takeda Pharmaceuticals U.S.A., Inc.
$58
Avadel CNS Pharmaceuticals, LLC
$52
Philips Electronics North America Corporation
$51
GENZYME CORPORATION
$45
Janssen Biotech, Inc.
$44
Novo Nordisk Inc
$43
Sunovion Pharmaceuticals Inc.
$42
HARMONY BIOSCIENCES LLC
$37
Insmed, Inc.
$34
Fresenius Kabi USA, LLC
$34
Axsome Therapeutics, Inc.
$30
Regeneron Healthcare Solutions, Inc.
$30
JAZZ PHARMACEUTICALS INC.
$28
Harmony Biosciences LLC
$27
Exact Sciences Corporation
$24
DePuy Synthes Sales Inc.
$23
Horizon Therapeutics plc
$16
Horizon Pharma plc
$15
ALK-Abello, Inc
$14
Alexion Pharmaceuticals, Inc.
$14
MannKind Corporation
$14
Mylan Specialty L.P.
$14
Mallinckrodt Hospital Products Inc.
$14
Teva Pharmaceuticals USA, Inc.
$13
Top 3 companies account for 67.8% of all-time payments
Associated products mentioned in payments ›
(8874) inCourage · ACTHAR · AFREZZA · AIRSUPRA · ANORO · ANORO ELLIPTA · AREXVY · Amitiza · Arikayce · BENLYSTA · BREO · BREZTRI · BRILINTA · BROVANA · CINQAIR · Cologuard Collection Kit · DUPIXENT · ELIQUIS · EVENITY · Enbrel · FARXIGA · FASENRA · IDACIO · KEVZARA · KRYSTEXXA · LONHALA MAGNAIR · LUMRYZ · LYRICA · NUCALA · OFEV · OPSUMIT · ORTHOVISC · Odactra · Ozempic · PREVNAR - 13 · PREVNAR 20 · RAYOS · REMICADE · Rybelsus · SHINGRIX · SIMPONI ARIA · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · STRENSIQ · SUNOSI · SYMBICORT · Sunosi · TAVNEOS · TRELEGY ELLIPTA · TRULICITY · Tavneos · Tymlos · Uloric · Victoza · Wakix · Yupelri · inCourage
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Pulmonary diseases within 10 mi
584
Per 100K population
112.7
County median income
$87,137
Nearest hospital
ESSEX COUNTY HOSPITAL CENTER
2.1 mi
2.1 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Chatterjee is a clinical cardiology specialist, with above-average Medicare volume (top 4% in NJ), with low-engagement industry engagement, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Chatterjee experienced with dexamethasone injection (steroid)?
Based on Medicare claims data, Dr. Chatterjee performed 1,610 dexamethasone injection (steroid) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Chatterjee receive payments from pharmaceutical companies?
Yes. Dr. Chatterjee received a total of $4,150 from 32 companies across 246 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Chatterjee's costs compare to other pulmonary diseases in West Paterson?
Dr. Chatterjee's average Medicare payment per service is $39. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Chatterjee) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Pulmonary Disease
Common procedures, typical costs, and what industry payments mean in pulmonary disease.
Same specialty & city
Pulmonary Diseases in West Paterson
Browse pulmonary diseases in West Paterson ranked by procedure volume and transparency data.
Highest volume
Top Pulmonary Diseases in NJ
Pulmonary diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Pulmonary Diseases in NJ
Which NJ pulmonary diseases receive the most from drug and device companies.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Boehringer Ingelheim Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Boehringer Ingelheim Pharmaceuticals, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology